187 related articles for article (PubMed ID: 8636365)
21. A Val 677 activating mutation of the thyrotropin receptor in a Hürthle cell thyroid carcinoma associated with thyrotoxicosis.
Russo D; Wong MG; Costante G; Chiefari E; Treseler PA; Arturi F; Filetti S; Clark OH
Thyroid; 1999 Jan; 9(1):13-7. PubMed ID: 10037070
[TBL] [Abstract][Full Text] [Related]
22. Two rare TSH receptor amino acid substitutions in toxic thyroid adenomas.
Nanba K; Usui T; Minamiguchi S; Mori Y; Watanabe Y; Honda K; Asato R; Nakao K; Kawashima ST; Yuno A; Tamanaha T; Tagami T; Naruse M; Akiyama Y; Shimatsu A
Endocr J; 2012; 59(1):13-9. PubMed ID: 22001338
[TBL] [Abstract][Full Text] [Related]
23. The thyrotropin receptor (TSH-R) is not an oncogene for thyroid tumors: structural studies of the TSH-R and the alpha-subunit of Gs in human thyroid neoplasms.
Matsuo K; Friedman E; Gejman PV; Fagin JA
J Clin Endocrinol Metab; 1993 Jun; 76(6):1446-51. PubMed ID: 8501149
[TBL] [Abstract][Full Text] [Related]
24. Thyroid hyperfunctioning adenomas with and without Gsp/TSH receptor mutations show similar clinical features.
Arturi F; Capula C; Chiefari E; Filetti S; Russo D
Exp Clin Endocrinol Diabetes; 1998; 106(3):234-6. PubMed ID: 9710366
[TBL] [Abstract][Full Text] [Related]
25. Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alpha genes as a cause of toxic thyroid adenomas.
Parma J; Duprez L; Van Sande J; Hermans J; Rocmans P; Van Vliet G; Costagliola S; Rodien P; Dumont JE; Vassart G
J Clin Endocrinol Metab; 1997 Aug; 82(8):2695-701. PubMed ID: 9253356
[TBL] [Abstract][Full Text] [Related]
26. Identification and functional characterization of two novel activating thyrotropin receptor mutants in toxic thyroid follicular adenomas.
Castro I; Lima L; Seoane R; Lado-Abeal J
Thyroid; 2009 Jun; 19(6):645-9. PubMed ID: 19499991
[TBL] [Abstract][Full Text] [Related]
27. Point mutations in the thyrotropin receptor in human thyroid tumors.
Ohno M; Endo T; Ohta K; Gunji K; Onaya T
Thyroid; 1995 Apr; 5(2):97-100. PubMed ID: 7647578
[TBL] [Abstract][Full Text] [Related]
28. Analysis of thyroid stimulating hormone-receptor mutations by temperature-gradient gel electrophoresis.
Koch M; Wahl R; Seif FJ
Electrophoresis; 1995 May; 16(5):742-3. PubMed ID: 7588555
[TBL] [Abstract][Full Text] [Related]
29. The detection of somatic mutations of thyrotropin receptor gene in fine needle biopsy samples from thyroid nodules.
Syrenicz A; Kurzawski G; Ciechanowicz A
Endocr Regul; 1999 Sep; 33(3):95-101. PubMed ID: 10571960
[TBL] [Abstract][Full Text] [Related]
30. Feline thyroid adenomas are in part associated with mutations in the G(s alpha) gene and not with polymorphisms found in the thyrotropin receptor.
Peeters ME; Timmermans-Sprang EP; Mol JA
Thyroid; 2002 Jul; 12(7):571-5. PubMed ID: 12193300
[TBL] [Abstract][Full Text] [Related]
31. Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma.
Russo D; Tumino S; Arturi F; Vigneri P; Grasso G; Pontecorvi A; Filetti S; Belfiore A
J Clin Endocrinol Metab; 1997 Mar; 82(3):735-8. PubMed ID: 9062474
[TBL] [Abstract][Full Text] [Related]
32. New pathophysiological mechanisms for hyperthyroidism.
Vassart G
Horm Res; 1997; 48 Suppl 4():47-50. PubMed ID: 9350447
[TBL] [Abstract][Full Text] [Related]
33. Two novel mutations in the sixth transmembrane segment of the thyrotropin receptor gene causing hyperfunctioning thyroid nodules.
Gozu H; Avsar M; Bircan R; Claus M; Sahin S; Sezgin O; Deyneli O; Paschke R; Cirakoglu B; Akalin S
Thyroid; 2005 Apr; 15(4):389-97. PubMed ID: 15876166
[TBL] [Abstract][Full Text] [Related]
34. Constitutively activating mutations of the thyrotropin receptor and thyroid disease.
Führer D; Holzapfel HP; Wonerow P; Paschke R
Eur J Med Res; 1996 Jul; 1(10):460-4. PubMed ID: 9438142
[TBL] [Abstract][Full Text] [Related]
35. Germline polymorphism of codon 727 of human thyroid-stimulating hormone receptor is associated with toxic multinodular goiter.
Gabriel EM; Bergert ER; Grant CS; van Heerden JA; Thompson GB; Morris JC
J Clin Endocrinol Metab; 1999 Sep; 84(9):3328-35. PubMed ID: 10487707
[TBL] [Abstract][Full Text] [Related]
36. [Non-autoimmune hyperthyroidism and hyperfunctioning thyroid adenomas caused by activating mutation of the thyrotropin receptor].
Kosugi S
Nihon Rinsho; 2002 Feb; 60(2):291-6. PubMed ID: 11857916
[TBL] [Abstract][Full Text] [Related]
37. The 3',5'-cyclic adenosine monophosphate response element binding protein (CREB) is functionally reduced in human toxic thyroid adenomas.
Brunetti A; Chiefari E; Filetti S; Russo D
Endocrinology; 2000 Feb; 141(2):722-30. PubMed ID: 10650954
[TBL] [Abstract][Full Text] [Related]
38. Mutations of the adenomatous polyposis coli gene in sporadic thyroid neoplasms.
Zeki K; Spambalg D; Sharifi N; Gonsky R; Fagin JA
J Clin Endocrinol Metab; 1994 Nov; 79(5):1317-21. PubMed ID: 7962323
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of mutations in TSHR, GNAS, PRKAR1A and RAS genes in a large series of toxic thyroid adenomas from Galicia, an iodine-deficient area in NW Spain.
Palos-Paz F; Perez-Guerra O; Cameselle-Teijeiro J; Rueda-Chimeno C; Barreiro-Morandeira F; Lado-Abeal J; ; Araujo Vilar D; Argueso R; Barca O; Botana M; Cabezas-Agrícola JM; Catalina P; Dominguez Gerpe L; Fernandez T; Mato A; Nuño A; Penin M; Victoria B
Eur J Endocrinol; 2008 Nov; 159(5):623-31. PubMed ID: 18694911
[TBL] [Abstract][Full Text] [Related]
40. Activating TSH-receptor mutation (Met453Thr) as a cause of adenomatous non-autoimmune hyperthyroidism in a 3-year-old boy.
Kraemer S; Rothe K; Pfaeffle R; Fuehrer-Sakel D; Till H; Muensterer OJ
J Pediatr Endocrinol Metab; 2009 Mar; 22(3):269-74. PubMed ID: 19492584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
